Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure

Journal of the American College of Cardiology

Volumn 27, Issue 3, 1996, Pages 633-641

  Pacher, Richard ^a   Stanek, Brigitte ^a   Hülsmann, Martin ^a   Koller Strametz, Jeanette ^a   Berger, Rudolf ^a   Schuller, Markus ^a   Hartter, Engelbert ^b   Ogris, Emil ^b   Frey, Bernhard ^a   Heinz, Gottfried ^a   Maurer, Gerald ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b DANUBE HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; ENDOTHELIN 1; FUROSEMIDE; RENIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0029880929     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00520-X     Document Type: Article

References (30)

1. Copeland J, Emery R, Levinson M. et al. I Selection of patients for cardiac transplantation. Circulation 1987:75:2-9.
2. Keogh AM, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990;65:903-8.
3. Parameshwar J, Keegan J, Sparrow GC, Sutton P, Puole-Wilson A. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992;123:421-6.
4. Mancini DM, Eisen H, Kussmaul W, Mull RL, Edmunds H Jr, Wilson JR. Value of peak oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-86.
5. Gottlieb SS, Marrick LK, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989;13:1534-9.
6. Lerman A, Gibbons RJ, Rodeheffer RJ, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-9.
7. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
8. Yanagisawa M, Kurihara S, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
9. Miller WL, Redfield MM, Burnett JC. Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 1989;83:317-20.
10. Cody RJ, Haas GJ, Binkley PF, Capers O, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-9.
11. Lerman A, Hildebrand FL Jr, Margulies KB, et al. Endothelin: a new cardiovascular regulatory peptide. Mayo Clin Proc 1990;65:1441-5.
12. Hiroe M, Hirata Y, Fujita N, et al. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:1114-5.
13. McMurray JJ, Ray SG, Abdullah I, Dergic HJ, Morion JJ. Plasma endothelin in chronic heart failure. Circulation 1992;85:1374-9.
14. Rodeheffer RJ, Lerman A, Heublein DM, Burnett JC. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 1992;67:719-24.
15. Pacher R, Bergler-Klein J, Globits S, et al. Plasma big endothelin-1 concentrations in congestive heart failure compared to systemic hypertension. Am J Cardiol 1993;71:1293-9.
16. Wei CM, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive heart failure. Circulation 1994;89:1580-6.
17. Lerman A, Hildebrand FL Jr, Aarhus LL, Burnett JC Jr. Endothelin has biological actions at pathophysiological concentrations. Circulation 1991;83: 1808-14.
18. Terashita Z, Shibouta Y, Imura Y, Iwasaki K, Nishikawa K. Endothelin-induced sudden death and the possible involvement of platelet activating factor (PAF). Life Sci 1989;45:1911-8.
19. Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year-mortality after acute myocardial infarction. Circulation 1994;98:1573-9.
20. Schuller M, Stetter R, Skrabal S, Missbichler A, Woloszczuk W, Hartter E. Radioimmunoassay of immunoreactive C-terminal big-endothelin. Eur J Clin Chem Clin Biochem 1991;29:147-50.
21. Eriksson BM, Persson BA. Determination of catecholamincs in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr 1982;228:143-54.
22. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-96.
23. Krum H, Goldsmith R, Wilshire-Clement M, Miller M, Packer M. Role of endothelin in the exercise intolerance of chronic heart failure. Am J Cardiol 1995;75:1282-3.
24. Packer M, Medina N, Yushak M. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders. Am J Cardiol 1984;54:771-7.
25. Stanek B, Pacher R, Berger R, et al. Sequential measurement of neurohumoral activity in severe heart failure: influence of different enalapril dosages [abstract]. J Heart Failure 1995;2:981.
26. Emori T, Hirata Y, Ohta K, et al. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension 1991;18:165-70.
27. Good JM, Nihoyannopoulos P, Ghatei MA, et al. Elevated plasma endothelin concentrations in heart failure: an effect of angiotensin II? Eur Heart J 1994;15:1634-40.
28. Pernow J, Hemsen A, Lundberg JM. Tissue specific distribution, clearance and vascular effects of endothelin in the pig. Biochem Biophys Res Commun 1989;161:647-53.
29. De Nucci G, Thomas R, Dórleans-Juste P. et al. Pressor effects of circulating endothelin arc limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-800.
30. Wagner OF, Vierhapper H, Gasic S, Nowotny P, Waldhäusl W. Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation. Eur J Clin Invest 1992;22:277-82.